RMRajbardhan Mishra

Rajbardhan Mishra

*This is an algorithmically generated author record based on publicly available information.

Rajbardhan Mishra has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 December 2015
      • Vol. 35  (12) , 6539-49

    Tumour Progression and Spontaneous Regression in the Lewis Rat Sarcoma Model.

    by Jana Kovalská, Rajbardhan Mishra, Lukáš Jebavý, Peter Makovický, Jozef Janda, Daniela Plánská, Monika Cervinkova, Vratislav Horak

    Spontaneous regression of tumours is a fascinating phenomenon rarely observed in oncological patients. We used a Lewis rat sarcoma model in which subcutaneous tumours developed after inoculation of the R5-28/clone C4 cells. Rats with tumour progression showed splenomegaly and anaemia. Tumour growth was associated with leucocytosis, granulocytosis, decrease in lymphocyte and CD161(+) population in peripheral blood and increase in serum MCP1 concentration. Animals with spontaneous regression of tumours initially showed an increase in white blood cells number and proportion of granulocytes. Between the 42nd and 49th day, however, values of these parameters dropped in correlation with reduction of tumour size. In spontaneously regressed tumours, vascularization was higher and on the contrary, progressive tumours had more necrotic areas with a high number of infiltrating granulocytes. In conclusion, progression and spontaneous regression of tumours in the Lewis rat sarcoma model is associated with distinct changes in populations of blood cells and immune cells which participate in these completely different processes of tumourigenesis.

    • 1 February 2015
      • Vol. 35  (2) , 703-11

    Tumor progression is associated with increasing CD11b+ cells and CCL2 in Lewis rat sarcoma.

    by Rajbardhan Mishra, Jana Kovalska, Jozef Janda, Luca Vannucci, Radko Rajmon, Vratislav Horak

    Tumor models are essential for basic anticancer research and development of novel therapies. In this study, we used a rat sarcoma model in which subcutaneous tumor develops after D6 cell inoculation. The aim of the current study was to analyze changes in haematological parameters, immune cell sub-populations and cytokine profiling during tumor growth, after tumor excision and after second inoculation of D6 cells. Tumor progression was found to be associated with an increased number of leukocytes and increased proportion of CD11b+ cells in peripheral blood. Serum concentration of chemokine (c-c motif) ligand 2, L-selectin and intra cellular adhesion molecule-1 also increased with growing tumor. However, the proportion of CD4+, CD8+ and MHC II+ cells decreased with growth of tumors. After tumor excision, all these parameters returned to pre-inoculation levels and did not change even after a second inoculation of D6 cells. Moreover, absence of secondary tumors after second inoculation of D6 cells gives an insight into development of antitumor immunity stimulated by primary tumor.